BBP holdings
Virtus Biotech ETF
Positions
70 stored of 70 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CRINETICS PHARMACEUTICALS INC CRINETICS PHARMACEUTICALS INC COM | US22663K1079 | 22663K107 | 3.337% | $3.3M | Equity (common) | Corporate | United States | USD |
| 2 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC KINIKSA PHARMACEUTICALS INTERNATIONAL PLC ORD SHS CL A | GB00BRXB0C07 | Not reported | 1.973% | $1.9M | Equity (common) | Corporate | United Kingdom | USD |
| 3 | VERASTEM INC VERASTEM INC COM NEW | US92337C2035 | 92337C203 | 1.948% | $1.9M | Equity (common) | Corporate | United States | USD |
| 4 | PRECIGEN INC PRECIGEN INC COM | US74017N1054 | 74017N105 | 1.940% | $1.9M | Equity (common) | Corporate | United States | USD |
| 5 | OMEROS CORP OMEROS CORP COM | US6821431029 | 682143102 | 1.867% | $1.8M | Equity (common) | Corporate | United States | USD |
| 6 | NUVATION BIO INC NUVATION BIO INC COM CL A | US67080N1019 | 67080N101 | 1.772% | $1.7M | Equity (common) | Corporate | United States | USD |
| 7 | REGENERON PHARMACEUTICALS REGENERON PHARMACEUTICALS INC | US75886F1075 | 75886F107 | 1.717% | $1.7M | Equity (common) | Corporate | United States | USD |
| 8 | PROTAGONIST THERAPEUTICS INC PROTAGONIST THERAPEUTICS INC COM | US74366E1029 | 74366E102 | 1.714% | $1.7M | Equity (common) | Corporate | United States | USD |
| 9 | ACADIA PHARMACEUTICALS INC ACADIA PHARMACEUTICALS INC COM | US0042251084 | 004225108 | 1.689% | $1.7M | Equity (common) | Corporate | United States | USD |
| 10 | BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC COM | US10806X1028 | 10806X102 | 1.651% | $1.6M | Equity (common) | Corporate | United States | USD |
| 11 | BEONE MEDICINES LTD BEONE MEDICINES LTD SPONSORED ADS | US07725L1026 | 07725L102 | 1.646% | $1.6M | Equity (common) | Corporate | Switzerland | USD |
| 12 | XERIS BIOPHARMA HOLDINGS INC XERIS BIOPHARMA HOLDINGS INC COM | US98422E1038 | 98422E103 | 1.639% | $1.6M | Equity (common) | Corporate | United States | USD |
| 13 | HALOZYME THERAPEUTICS INC | US40637H1095 | 40637H109 | 1.636% | $1.6M | Equity (common) | Corporate | United States | USD |
| 14 | LIQUIDIA CORP LIQUIDIA CORP COM NEW | US53635D2027 | 53635D202 | 1.626% | $1.6M | Equity (common) | Corporate | United States | USD |
| 15 | IMMUNOCORE HOLDINGS PLC IMMUNOCORE HOLDINGS PLC ADS | US45258D1054 | 45258D105 | 1.608% | $1.6M | Equity (common) | Corporate | United Kingdom | USD |
| 16 | IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS INC COM CL A | US46333X1081 | 46333X108 | 1.596% | $1.6M | Equity (common) | Corporate | United States | USD |
| 17 | ARROWHEAD PHARMACEUTICALS INC ARROWHEAD PHARMACEUTICALS INC COM | US04280A1007 | 04280A100 | 1.564% | $1.5M | Equity (common) | Corporate | United States | USD |
| 18 | ROIVANT SCIENCES LTD ROIVANT SCIENCES LTD SHS | BMG762791017 | Not reported | 1.555% | $1.5M | Equity (common) | Corporate | Bermuda | USD |
| 19 | LIGAND PHARMACEUTICALS LIGAND PHARMACEUTICALS INC | US53220K5048 | 53220K504 | 1.549% | $1.5M | Equity (common) | Corporate | United States | USD |
| 20 | RHYTHM PHARMACEUTICALS INC RHYTHM PHARMACEUTICALS INC COM | US76243J1051 | 76243J105 | 1.547% | $1.5M | Equity (common) | Corporate | United States | USD |
| 21 | GERON CORP GERON CORP COM | US3741631036 | 374163103 | 1.545% | $1.5M | Equity (common) | Corporate | United States | USD |
| 22 | RIGEL PHARMACEUTICALS INC RIGEL PHARMACEUTICALS INC COM | US7665597024 | 766559702 | 1.543% | $1.5M | Equity (common) | Corporate | United States | USD |
| 23 | ASCENDIS PHARMA A/S ASCENDIS PHARMA A/S ORD SHS | DK0060615755 | Not reported | 1.541% | $1.5M | Equity (common) | Corporate | Denmark | USD |
| 24 | ARCUTIS BIOTHERAPEUTICS INC ARCUTIS BIOTHERAPEUTICS INC COM | US03969K1088 | 03969K108 | 1.517% | $1.5M | Equity (common) | Corporate | United States | USD |
| 25 | INCYTE CORP | US45337C1027 | 45337C102 | 1.517% | $1.5M | Equity (common) | Corporate | United States | USD |
| 26 | CYTOKINETICS INC CYTOKINETICS INC COM NEW | US23282W6057 | 23282W605 | 1.514% | $1.5M | Equity (common) | Corporate | United States | USD |
| 27 | MODERNA INC MODERNA INC COM | US60770K1079 | 60770K107 | 1.513% | $1.5M | Equity (common) | Corporate | United States | USD |
| 28 | AMGEN INC AMGEN INC COM | US0311621009 | 031162100 | 1.493% | $1.5M | Equity (common) | Corporate | United States | USD |
| 29 | TRAVERE THERAPEUTICS INC TRAVERE THERAPEUTICS INC COM | US89422G1076 | 89422G107 | 1.479% | $1.5M | Equity (common) | Corporate | United States | USD |
| 30 | KRYSTAL BIOTECH INC KRYSTAL BIOTECH INC COM | US5011471027 | 501147102 | 1.478% | $1.5M | Equity (common) | Corporate | United States | USD |
| 31 | VERTEX PHARMACEUTICALS INC | US92532F1003 | 92532F100 | 1.478% | $1.5M | Equity (common) | Corporate | United States | USD |
| 32 | BIOMARIN PHARMACEUTICAL INC | US09061G1013 | 09061G101 | 1.477% | $1.5M | Equity (common) | Corporate | United States | USD |
| 33 | ZAI LAB LTD ZAI LAB LTD ADR | US98887Q1040 | 98887Q104 | 1.474% | $1.5M | Equity (common) | Corporate | Cayman Islands | USD |
| 34 | MIRUM PHARMACEUTICALS INC MIRUM PHARMACEUTICALS INC COM | US6047491013 | 604749101 | 1.469% | $1.4M | Equity (common) | Corporate | United States | USD |
| 35 | DENALI THERAPEUTICS INC DENALI THERAPEUTICS INC COM | US24823R1059 | 24823R105 | 1.464% | $1.4M | Equity (common) | Corporate | United States | USD |
| 36 | TG THERAPEUTICS INC TG THERAPEUTICS INC COM | US88322Q1085 | 88322Q108 | 1.447% | $1.4M | Equity (common) | Corporate | United States | USD |
| 37 | NEUROCRINE BIOSCIENCES INC | US64125C1099 | 64125C109 | 1.438% | $1.4M | Equity (common) | Corporate | United States | USD |
| 38 | SYNDAX PHARMACEUTICALS INC SYNDAX PHARMACEUTICALS INC COM | US87164F1057 | 87164F105 | 1.438% | $1.4M | Equity (common) | Corporate | United States | USD |
| 39 | GILEAD SCIENCES INC | US3755581036 | 375558103 | 1.428% | $1.4M | Equity (common) | Corporate | United States | USD |
| 40 | BIOCRYST PHARMACEUTICALS INC BIOCRYST PHARMACEUTICALS INC COM | US09058V1035 | 09058V103 | 1.422% | $1.4M | Equity (common) | Corporate | United States | USD |
| 41 | ADMA BIOLOGICS INC ADMA BIOLOGICS INC COM | US0008991046 | 000899104 | 1.419% | $1.4M | Equity (common) | Corporate | United States | USD |
| 42 | ULTRAGENYX PHARMACEUTICAL IN ULTRAGENYX PHARMACEUTICAL INC | US90400D1081 | 90400D108 | 1.409% | $1.4M | Equity (common) | Corporate | United States | USD |
| 43 | HARMONY BIOSCIENCES HOLDINGS INC HARMONY BIOSCIENCES HOLDINGS INC COM | US4131971040 | 413197104 | 1.408% | $1.4M | Equity (common) | Corporate | United States | USD |
| 44 | AGIOS PHARMACEUTICALS INC | US00847X1046 | 00847X104 | 1.403% | $1.4M | Equity (common) | Corporate | United States | USD |
| 45 | BIOGEN INC | US09062X1037 | 09062X103 | 1.397% | $1.4M | Equity (common) | Corporate | United States | USD |
| 46 | THERAVANCE BIOPHARMA INC | KYG8807B1068 | Not reported | 1.395% | $1.4M | Equity (common) | Corporate | Cayman Islands | USD |
| 47 | IMMUNITYBIO INC IMMUNITYBIO INC COM | US45256X1037 | 45256X103 | 1.391% | $1.4M | Equity (common) | Corporate | United States | USD |
| 48 | INSMED INC INSMED INC COM PAR $.01 | US4576693075 | 457669307 | 1.388% | $1.4M | Equity (common) | Corporate | United States | USD |
| 49 | BIONTECH SE BIONTECH SE SPONSORED ADS | US09075V1026 | 09075V102 | 1.378% | $1.4M | Equity (common) | Corporate | Germany | USD |
| 50 | EXELIXIS INC | US30161Q1040 | 30161Q104 | 1.375% | $1.4M | Equity (common) | Corporate | United States | USD |
| 51 | IOVANCE BIOTHERAPEUTICS INC IOVANCE BIOTHERAPEUTICS INC COM | US4622601007 | 462260100 | 1.374% | $1.4M | Equity (common) | Corporate | United States | USD |
| 52 | KURA ONCOLOGY INC KURA ONCOLOGY INC COM | US50127T1097 | 50127T109 | 1.371% | $1.4M | Equity (common) | Corporate | United States | USD |
| 53 | MADRIGAL PHARMACEUTICALS INC MADRIGAL PHARMACEUTICALS INC COM | US5588681057 | 558868105 | 1.339% | $1.3M | Equity (common) | Corporate | United States | USD |
| 54 | SAREPTA THERAPEUTICS INC | US8036071004 | 803607100 | 1.337% | $1.3M | Equity (common) | Corporate | United States | USD |
| 55 | CRISPR THERAPEUTICS AG CRISPR THERAPEUTICS AG NAMEN AKT | CH0334081137 | Not reported | 1.327% | $1.3M | Equity (common) | Corporate | Switzerland | USD |
| 56 | ZYMEWORKS INC ZYMEWORKS INC COM | US98985Y1082 | 98985Y108 | 1.321% | $1.3M | Equity (common) | Corporate | United States | USD |
| 57 | TARSUS PHARMACEUTICALS INC TARSUS PHARMACEUTICALS INC COM | US87650L1035 | 87650L103 | 1.312% | $1.3M | Equity (common) | Corporate | United States | USD |
| 58 | UNITED THERAPEUTICS CORP | US91307C1027 | 91307C102 | 1.307% | $1.3M | Equity (common) | Corporate | United States | USD |
| 59 | AURINIA PHARMACEUTICALS INC AURINIA PHARMACEUTICALS INC COM | CA05156V1022 | 05156V102 | 1.295% | $1.3M | Equity (common) | Corporate | Canada | USD |
| 60 | PTC THERAPEUTICS INC PTC THERAPEUTICS INC COM | US69366J2006 | 69366J200 | 1.247% | $1.2M | Equity (common) | Corporate | United States | USD |
| 61 | ARDELYX INC ARDELYX INC COM | US0396971071 | 039697107 | 1.198% | $1.2M | Equity (common) | Corporate | United States | USD |
| 62 | AXSOME THERAPEUTICS INC AXSOME THERAPEUTICS INC COM | US05464T1043 | 05464T104 | 1.177% | $1.2M | Equity (common) | Corporate | United States | USD |
| 63 | PHATHOM PHARMACEUTICALS INC PHATHOM PHARMACEUTICALS INC COM | US71722W1071 | 71722W107 | 1.162% | $1.1M | Equity (common) | Corporate | United States | USD |
| 64 | NOVAVAX INC NOVAVAX INC COM NEW | US6700024010 | 670002401 | 1.135% | $1.1M | Equity (common) | Corporate | United States | USD |
| 65 | ALNYLAM PHARMACEUTICALS INC ALNYLAM PHARMACEUTICALS INC COM | US02043Q1076 | 02043Q107 | 1.001% | $986K | Equity (common) | Corporate | United States | USD |
| 66 | IONIS PHARMACEUTICALS INC | US4622221004 | 462222100 | 0.973% | $959K | Equity (common) | Corporate | United States | USD |
| 67 | LEGEND BIOTECH CORP LEGEND BIOTECH CORP SPONSORED ADS | US52490G1022 | 52490G102 | 0.712% | $702K | Equity (common) | Corporate | Cayman Islands | USD |
| 68 | DREYFUS GOVERNMENT CASH MANAGE | Not reported | Not reported | 0.708% | $698K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 69 | OMNIAB INC OMNIAB INC USD0.0001 A (USD15 VESTING) | US68218J3014 | 68218J301 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 70 | OMNIAB INC OMNIAB INC USD0.0001 A (USD12.5 VESTING) | US68218J2024 | 68218J202 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |